Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis.
Br J Dermatol
; 184(6): 1094-1105, 2021 06.
Article
in En
| MEDLINE
| ID: mdl-33289075
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Biological Products
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Br J Dermatol
Year:
2021
Document type:
Article
Affiliation country:
Austria
Country of publication:
Reino Unido